@FierceMedDev: Medtronic jumps into hemodialysis business through India partnership. ICYMI yesterday | Follow @FierceMedDev
@MarkHFierce: The head of Roche molecular diagnostics spoke to FierceDiagnostics recently about two key future products. More | Follow @MarkHFierce
@MichaelGFierce: Check out this week's FierceDrugDelivery newsletter! RNAi roundup & stem cell drug delivery action. Report | Follow @MichaelGFierce
> Neuros Medical secured the FDA's blessing to conduct a pivotal trial of its Altius neuromodulation device, which treats the intractable limb pain of amputees. More
> CardioDx's Corus CAD test is especially effective in women, according to a new study, providing early detection of obstructive coronary artery disease that could save more than $500 in medical costs per patient. Release
> Maquet picked up FDA clearance for its Volista surgical lighting system. News
> Florida's OrthoSenso gained a CE mark for Verasense, a sensor-based device designed to give surgeons data to help reduce misalignment and imbalance in a total knee replacement procedure. Item
> Integra LifeSciences Holdings ($IART) said it won 510(k) clearance for a set of new implants and instruments designed for use after open-door laminoplasty procedures in the cervical and thoracic spine. Item
> Sotera Wireless won FDA clearance for its new continuous non-invasive blood pressure technology, a key feature of its wireless patient monitoring system. Item
Biotech News
@FierceBiotech: Popular yesterday: 10 top drugs in biopharma's late-stage pipeline. Feature | Follow @FierceBiotech
@JohnCFierce: Few months after $60M C series and Forest deal, Trevena files for $86M IPO. SEC filing | Press release | Follow @JohnCFierce
@DamianFierce: MacroGenics has up-sized its IPO, now seeking $80M amid biotech blitz. ICYMI yesterday | Follow @DamianFierce
@EmilyMFierce: 3-D printing builds bacterial metropolises. More via ScienceNews | Follow @EmilyMFierce
> Google visionaries ready to invest a fortune in revolutionizing aging process. Article
> Takeda punts $620M antibody licensing pact with Immunomedics. Story
> Gilead scores early PhIII success for idelalisib in chronic lymphocytic leukemia. More
Pharma News
@FiercePharma: Top 10 Drugmakers in Emerging Markets--our latest special report. Feature | Follow @FiercePharma
@CarlyHFierce: Teva: Copying GlaxoSmithKline's Advair too tough for success before 2018. ICYMI yesterday | Follow @CarlyHFierce
> Which new drugs promise to shake up markets the most? Report
> Express Scripts stops covering key Big Pharma drugs on cost-effectiveness grounds. Story
> Teva plots 5,000 more job cuts in $2B savings drive. News
Pharma Manufacturing News
@EricPFierce: Will McKesson and AmerisourceBergen now face off in Europe? Article | Follow @EricPFierce
> Catalent moves on Brazil VMS, softgel market. News
> Vetter putting $100M into its production network. Report
> Teva looks for big savings from procurement, manufacturing. Story
> Feds fight drug imports Maine now allows. More
> BioCentury finds FDA has $270M in GDUFA, PDUFA fees in hand. Item
Vaccines News
> WHO prequalification moves China into global vaccine arena. Item
> Novartis opening vaccine R&D lab in North Carolina. Report
> Takeda's norovirus vaccine misses endpoint in early-phase trial. Story
> GSK targets 2015 launch for malaria vaccine. Article
> HIV trial follow-up quashes fears of infection risk. More